What we're reading, May 5, 2016: obtaining life-ending medications under California's new law won't be easy come June 9; Arizona is now the only state to not participate in CHIP; struggling insurers propose big premiums increases on Obamacare plans.
When California’s aid-in-dying legislation take effects in June, the process for terminally ill individuals to get medications to end their lives won’t be simple. According to Kaiser Health News, the legislation creates a long list of administrative hurdles for both patients and physicians. The reasons for there being so many steps is to ensure the patient has really thought about the decision and is making it voluntarily.
Arizona has chosen not to restore the federal Children’s Health Insurance Program, making it the only state to not participate in the program. The state’s House voted to restart the program with the caveat that the state can suspend it if fewer federal dollars came in, and the Senate let the bill die due to concerns about the provision, reported The New York Times. The state’s lawmakers initially froze enrollment into the program 6 years ago—30,000 children can enroll in the program, which represents 20% of the uninsured children in Arizona.
As some insurers struggle in the Affordable Care marketplaces, they are proposing big premium increases. The Wall Street Journal reported that the picture will vary state by state as some companies, such as Centene, are profitable, while others, like Humana, expect losses. Humana recently announced it would make changes to its exchange offerings next year, which follows from UnitedHealth Group’s announcement that it would withdraw from most state exchanges in 2017.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More